nodes	percent_of_prediction	percent_of_DWPC	metapath
Paclitaxel—lung cancer—kidney cancer	0.334	1	CtDrD
Paclitaxel—ABCB1—kidney cancer	0.0401	1	CbGaD
Paclitaxel—NR1I2—Erlotinib—kidney cancer	0.0169	0.0396	CbGbCtD
Paclitaxel—TUBB2A—Vinblastine—kidney cancer	0.0149	0.0349	CbGbCtD
Paclitaxel—TUBB6—Vinblastine—kidney cancer	0.0149	0.0349	CbGbCtD
Paclitaxel—TUBB8—Vinblastine—kidney cancer	0.0149	0.0349	CbGbCtD
Paclitaxel—TUBB4A—Vinblastine—kidney cancer	0.0149	0.0349	CbGbCtD
Paclitaxel—TUBB2B—Vinblastine—kidney cancer	0.0149	0.0349	CbGbCtD
Paclitaxel—TUBB3—Vinblastine—kidney cancer	0.0149	0.0349	CbGbCtD
Paclitaxel—TUBB4A—Vincristine—kidney cancer	0.0146	0.0344	CbGbCtD
Paclitaxel—TUBB3—Vincristine—kidney cancer	0.0146	0.0344	CbGbCtD
Paclitaxel—TUBB2A—Vincristine—kidney cancer	0.0146	0.0344	CbGbCtD
Paclitaxel—TUBB6—Vincristine—kidney cancer	0.0146	0.0344	CbGbCtD
Paclitaxel—TUBB8—Vincristine—kidney cancer	0.0146	0.0344	CbGbCtD
Paclitaxel—TUBB2B—Vincristine—kidney cancer	0.0146	0.0344	CbGbCtD
Paclitaxel—TUBB—Vinblastine—kidney cancer	0.0125	0.0292	CbGbCtD
Paclitaxel—TUBB4B—Vinblastine—kidney cancer	0.0125	0.0292	CbGbCtD
Paclitaxel—TUBB1—Vinblastine—kidney cancer	0.0125	0.0292	CbGbCtD
Paclitaxel—TUBB4B—Vincristine—kidney cancer	0.0122	0.0287	CbGbCtD
Paclitaxel—TUBB1—Vincristine—kidney cancer	0.0122	0.0287	CbGbCtD
Paclitaxel—TUBB—Vincristine—kidney cancer	0.0122	0.0287	CbGbCtD
Paclitaxel—ABCC10—Gemcitabine—kidney cancer	0.012	0.0282	CbGbCtD
Paclitaxel—ABCC10—Vincristine—kidney cancer	0.00935	0.022	CbGbCtD
Paclitaxel—CYP1B1—Erlotinib—kidney cancer	0.00644	0.0151	CbGbCtD
Paclitaxel—CYP3A7—Temsirolimus—kidney cancer	0.00603	0.0142	CbGbCtD
Paclitaxel—CYP3A7-CYP3A51P—Temsirolimus—kidney cancer	0.00603	0.0142	CbGbCtD
Paclitaxel—ABCC1—Dactinomycin—kidney cancer	0.00586	0.0138	CbGbCtD
Paclitaxel—ABCC10—Doxorubicin—kidney cancer	0.00585	0.0137	CbGbCtD
Paclitaxel—ABCB11—Vinblastine—kidney cancer	0.00517	0.0121	CbGbCtD
Paclitaxel—ABCB11—Vincristine—kidney cancer	0.00508	0.0119	CbGbCtD
Paclitaxel—CYP3A5—Temsirolimus—kidney cancer	0.00453	0.0106	CbGbCtD
Paclitaxel—ABCG2—Pazopanib—kidney cancer	0.00429	0.0101	CbGbCtD
Paclitaxel—ABCG2—Dactinomycin—kidney cancer	0.00392	0.00921	CbGbCtD
Paclitaxel—ABCC1—Vinblastine—kidney cancer	0.00367	0.00862	CbGbCtD
Paclitaxel—ABCC1—Vincristine—kidney cancer	0.00361	0.00848	CbGbCtD
Paclitaxel—ABCB11—Doxorubicin—kidney cancer	0.00318	0.00746	CbGbCtD
Paclitaxel—CYP1B1—Doxorubicin—kidney cancer	0.00318	0.00746	CbGbCtD
Paclitaxel—ABCG2—Erlotinib—kidney cancer	0.00306	0.00719	CbGbCtD
Paclitaxel—ABCB1—Temsirolimus—kidney cancer	0.00295	0.00691	CbGbCtD
Paclitaxel—ABCC2—Sorafenib—kidney cancer	0.00275	0.00646	CbGbCtD
Paclitaxel—ABCC2—Vinblastine—kidney cancer	0.00272	0.00638	CbGbCtD
Paclitaxel—ABCC2—Vincristine—kidney cancer	0.00267	0.00627	CbGbCtD
Paclitaxel—CYP3A4—Everolimus—kidney cancer	0.00261	0.00613	CbGbCtD
Paclitaxel—ABCG2—Sorafenib—kidney cancer	0.00249	0.00584	CbGbCtD
Paclitaxel—ABCG2—Vincristine—kidney cancer	0.00242	0.00567	CbGbCtD
Paclitaxel—CYP2C8—Pazopanib—kidney cancer	0.00229	0.00536	CbGbCtD
Paclitaxel—ABCC1—Doxorubicin—kidney cancer	0.00226	0.0053	CbGbCtD
Paclitaxel—ABCC2—Sunitinib—kidney cancer	0.00223	0.00524	CbGbCtD
Paclitaxel—ABCG2—Sunitinib—kidney cancer	0.00202	0.00473	CbGbCtD
Paclitaxel—CYP3A7—Sorafenib—kidney cancer	0.00184	0.00432	CbGbCtD
Paclitaxel—CYP3A7-CYP3A51P—Sorafenib—kidney cancer	0.00184	0.00432	CbGbCtD
Paclitaxel—CYP3A7-CYP3A51P—Vincristine—kidney cancer	0.00179	0.00419	CbGbCtD
Paclitaxel—CYP3A7—Vincristine—kidney cancer	0.00179	0.00419	CbGbCtD
Paclitaxel—CYP3A4—Temsirolimus—kidney cancer	0.00176	0.00414	CbGbCtD
Paclitaxel—CYP3A5—Erlotinib—kidney cancer	0.0017	0.00398	CbGbCtD
Paclitaxel—ABCC2—Doxorubicin—kidney cancer	0.00167	0.00392	CbGbCtD
Paclitaxel—CYP2C9—Capecitabine—kidney cancer	0.00166	0.0039	CbGbCtD
Paclitaxel—CYP2C8—Erlotinib—kidney cancer	0.00163	0.00383	CbGbCtD
Paclitaxel—ABCB1—Pazopanib—kidney cancer	0.00155	0.00363	CbGbCtD
Paclitaxel—ABCG2—Doxorubicin—kidney cancer	0.00151	0.00355	CbGbCtD
Paclitaxel—CYP3A7-CYP3A51P—Sunitinib—kidney cancer	0.00149	0.0035	CbGbCtD
Paclitaxel—CYP3A7—Sunitinib—kidney cancer	0.00149	0.0035	CbGbCtD
Paclitaxel—ABCB1—Dactinomycin—kidney cancer	0.00142	0.00332	CbGbCtD
Paclitaxel—CYP3A5—Sorafenib—kidney cancer	0.00138	0.00324	CbGbCtD
Paclitaxel—CYP3A5—Vincristine—kidney cancer	0.00134	0.00314	CbGbCtD
Paclitaxel—CYP2C8—Sorafenib—kidney cancer	0.00133	0.00311	CbGbCtD
Paclitaxel—ABCB1—Gemcitabine—kidney cancer	0.00112	0.00263	CbGbCtD
Paclitaxel—CYP3A5—Sunitinib—kidney cancer	0.00112	0.00262	CbGbCtD
Paclitaxel—ABCB1—Erlotinib—kidney cancer	0.0011	0.00259	CbGbCtD
Paclitaxel—MAPT—nephron tubule—kidney cancer	0.000977	0.0372	CbGeAlD
Paclitaxel—CYP3A4—Pazopanib—kidney cancer	0.000927	0.00218	CbGbCtD
Paclitaxel—CYP2C9—Sorafenib—kidney cancer	0.000925	0.00217	CbGbCtD
Paclitaxel—ABCB1—Sorafenib—kidney cancer	0.000898	0.00211	CbGbCtD
Paclitaxel—ABCB1—Vinblastine—kidney cancer	0.000886	0.00208	CbGbCtD
Paclitaxel—ABCB1—Vincristine—kidney cancer	0.000872	0.00205	CbGbCtD
Paclitaxel—MAPT—cortex of kidney—kidney cancer	0.000836	0.0318	CbGeAlD
Paclitaxel—CYP2C9—urine—kidney cancer	0.00073	0.0278	CbGeAlD
Paclitaxel—ABCB1—Sunitinib—kidney cancer	0.000727	0.00171	CbGbCtD
Paclitaxel—MAP4—renal system—kidney cancer	0.000698	0.0266	CbGeAlD
Paclitaxel—MAP4—kidney—kidney cancer	0.000675	0.0257	CbGeAlD
Paclitaxel—CYP3A4—Erlotinib—kidney cancer	0.000662	0.00155	CbGbCtD
Paclitaxel—MAP4—cortex of kidney—kidney cancer	0.000657	0.025	CbGeAlD
Paclitaxel—BCL2—renal system—kidney cancer	0.000635	0.0242	CbGeAlD
Paclitaxel—MAP4—gonad—kidney cancer	0.000626	0.0238	CbGeAlD
Paclitaxel—BCL2—kidney—kidney cancer	0.000614	0.0233	CbGeAlD
Paclitaxel—TUBB6—Zalcitabine—Gemcitabine—kidney cancer	0.000578	0.582	CbGdCrCtD
Paclitaxel—BCL2—gonad—kidney cancer	0.000569	0.0217	CbGeAlD
Paclitaxel—CYP3A4—urine—kidney cancer	0.000557	0.0212	CbGeAlD
Paclitaxel—ABCB1—Doxorubicin—kidney cancer	0.000545	0.00128	CbGbCtD
Paclitaxel—CYP3A4—Sorafenib—kidney cancer	0.000538	0.00126	CbGbCtD
Paclitaxel—CYP3A4—Vinblastine—kidney cancer	0.000531	0.00125	CbGbCtD
Paclitaxel—CYP3A4—Vincristine—kidney cancer	0.000522	0.00123	CbGbCtD
Paclitaxel—MAP2—cortex of kidney—kidney cancer	0.000518	0.0197	CbGeAlD
Paclitaxel—MAP2—gonad—kidney cancer	0.000493	0.0188	CbGeAlD
Paclitaxel—MAP2—cardiac atrium—kidney cancer	0.000492	0.0187	CbGeAlD
Paclitaxel—CYP3A7-CYP3A51P—nephron tubule—kidney cancer	0.000482	0.0183	CbGeAlD
Paclitaxel—TUBB2B—nephron tubule—kidney cancer	0.000452	0.0172	CbGeAlD
Paclitaxel—CYP3A4—Sunitinib—kidney cancer	0.000436	0.00102	CbGbCtD
Paclitaxel—TUBB—nephron tubule—kidney cancer	0.000428	0.0163	CbGeAlD
Paclitaxel—TUBB2A—nephron tubule—kidney cancer	0.000425	0.0162	CbGeAlD
Paclitaxel—TUBB4A—renal system—kidney cancer	0.000425	0.0162	CbGeAlD
Paclitaxel—TUBB6—nephron tubule—kidney cancer	0.000419	0.016	CbGeAlD
Paclitaxel—CYP3A7-CYP3A51P—cortex of kidney—kidney cancer	0.000413	0.0157	CbGeAlD
Paclitaxel—TUBB4A—kidney—kidney cancer	0.000411	0.0156	CbGeAlD
Paclitaxel—TUBB2B—renal system—kidney cancer	0.000411	0.0156	CbGeAlD
Paclitaxel—TUBB2B—cortex of kidney—kidney cancer	0.000387	0.0147	CbGeAlD
Paclitaxel—TUBB6—renal system—kidney cancer	0.000381	0.0145	CbGeAlD
Paclitaxel—TUBB4A—gonad—kidney cancer	0.000381	0.0145	CbGeAlD
Paclitaxel—TUBB6—kidney—kidney cancer	0.000369	0.014	CbGeAlD
Paclitaxel—TUBB2B—gonad—kidney cancer	0.000368	0.014	CbGeAlD
Paclitaxel—TUBB2B—cardiac atrium—kidney cancer	0.000368	0.014	CbGeAlD
Paclitaxel—TUBB—cortex of kidney—kidney cancer	0.000366	0.0139	CbGeAlD
Paclitaxel—TUBB4B—nephron tubule—kidney cancer	0.000365	0.0139	CbGeAlD
Paclitaxel—TUBB2A—cortex of kidney—kidney cancer	0.000364	0.0138	CbGeAlD
Paclitaxel—TUBB6—cortex of kidney—kidney cancer	0.000359	0.0137	CbGeAlD
Paclitaxel—TUBB—cardiac atrium—kidney cancer	0.000348	0.0132	CbGeAlD
Paclitaxel—TUBB2A—cardiac atrium—kidney cancer	0.000346	0.0132	CbGeAlD
Paclitaxel—TUBB6—gonad—kidney cancer	0.000342	0.013	CbGeAlD
Paclitaxel—TUBB6—cardiac atrium—kidney cancer	0.000341	0.013	CbGeAlD
Paclitaxel—ABCC10—renal system—kidney cancer	0.000334	0.0127	CbGeAlD
Paclitaxel—TUBB4B—renal system—kidney cancer	0.000331	0.0126	CbGeAlD
Paclitaxel—CYP3A4—Doxorubicin—kidney cancer	0.000326	0.000766	CbGbCtD
Paclitaxel—ABCC10—kidney—kidney cancer	0.000323	0.0123	CbGeAlD
Paclitaxel—TUBB4B—kidney—kidney cancer	0.00032	0.0122	CbGeAlD
Paclitaxel—ABCC10—cortex of kidney—kidney cancer	0.000314	0.012	CbGeAlD
Paclitaxel—TUBB4B—cortex of kidney—kidney cancer	0.000312	0.0119	CbGeAlD
Paclitaxel—ABCC10—gonad—kidney cancer	0.000299	0.0114	CbGeAlD
Paclitaxel—ABCC10—cardiac atrium—kidney cancer	0.000299	0.0114	CbGeAlD
Paclitaxel—TUBB4B—gonad—kidney cancer	0.000297	0.0113	CbGeAlD
Paclitaxel—TUBB4B—cardiac atrium—kidney cancer	0.000297	0.0113	CbGeAlD
Paclitaxel—ABCC2—nephron tubule—kidney cancer	0.000295	0.0112	CbGeAlD
Paclitaxel—TUBB—Azacitidine—Gemcitabine—kidney cancer	0.000294	0.296	CbGdCrCtD
Paclitaxel—CYP1B1—nephron tubule—kidney cancer	0.000289	0.011	CbGeAlD
Paclitaxel—ABCC2—renal system—kidney cancer	0.000268	0.0102	CbGeAlD
Paclitaxel—CYP1B1—renal system—kidney cancer	0.000263	0.00999	CbGeAlD
Paclitaxel—ABCC2—kidney—kidney cancer	0.000259	0.00986	CbGeAlD
Paclitaxel—CYP1B1—kidney—kidney cancer	0.000254	0.00966	CbGeAlD
Paclitaxel—ABCC2—cortex of kidney—kidney cancer	0.000252	0.0096	CbGeAlD
Paclitaxel—CYP19A1—gonad—kidney cancer	0.000252	0.00958	CbGeAlD
Paclitaxel—CYP1B1—cortex of kidney—kidney cancer	0.000247	0.0094	CbGeAlD
Paclitaxel—CYP1B1—gonad—kidney cancer	0.000235	0.00896	CbGeAlD
Paclitaxel—ABCC1—cortex of kidney—kidney cancer	0.000222	0.00846	CbGeAlD
Paclitaxel—ABCG2—nephron tubule—kidney cancer	0.000215	0.00818	CbGeAlD
Paclitaxel—ABCC1—cardiac atrium—kidney cancer	0.000211	0.00805	CbGeAlD
Paclitaxel—CYP2C8—renal system—kidney cancer	0.000201	0.00765	CbGeAlD
Paclitaxel—CYP3A5—nephron tubule—kidney cancer	0.0002	0.00759	CbGeAlD
Paclitaxel—CYP2C8—kidney—kidney cancer	0.000194	0.00739	CbGeAlD
Paclitaxel—Cabazitaxel—ABCB1—kidney cancer	0.000182	0.553	CrCbGaD
Paclitaxel—CYP3A5—renal system—kidney cancer	0.000181	0.0069	CbGeAlD
Paclitaxel—CYP3A5—kidney—kidney cancer	0.000175	0.00667	CbGeAlD
Paclitaxel—CYP3A5—cortex of kidney—kidney cancer	0.000171	0.0065	CbGeAlD
Paclitaxel—Docetaxel—ABCB1—kidney cancer	0.000147	0.447	CrCbGaD
Paclitaxel—CYP3A4—renal system—kidney cancer	0.000136	0.00518	CbGeAlD
Paclitaxel—CYP3A4—kidney—kidney cancer	0.000132	0.00501	CbGeAlD
Paclitaxel—TUBB6—Azacitidine—Gemcitabine—kidney cancer	0.000121	0.122	CbGdCrCtD
Paclitaxel—ABCB1—nephron tubule—kidney cancer	0.000106	0.00403	CbGeAlD
Paclitaxel—ABCB1—renal system—kidney cancer	9.64e-05	0.00367	CbGeAlD
Paclitaxel—ABCB1—kidney—kidney cancer	9.32e-05	0.00355	CbGeAlD
Paclitaxel—ABCB1—cortex of kidney—kidney cancer	9.08e-05	0.00345	CbGeAlD
Paclitaxel—ABCB1—gonad—kidney cancer	8.64e-05	0.00329	CbGeAlD
Paclitaxel—Nausea—Everolimus—kidney cancer	1.85e-05	0.000155	CcSEcCtD
Paclitaxel—Diarrhoea—Sorafenib—kidney cancer	1.85e-05	0.000155	CcSEcCtD
Paclitaxel—Pruritus—Sunitinib—kidney cancer	1.84e-05	0.000154	CcSEcCtD
Paclitaxel—Angiopathy—Capecitabine—kidney cancer	1.84e-05	0.000154	CcSEcCtD
Paclitaxel—Immune system disorder—Capecitabine—kidney cancer	1.83e-05	0.000153	CcSEcCtD
Paclitaxel—Mediastinal disorder—Capecitabine—kidney cancer	1.82e-05	0.000153	CcSEcCtD
Paclitaxel—Decreased appetite—Gemcitabine—kidney cancer	1.82e-05	0.000152	CcSEcCtD
Paclitaxel—Hypersensitivity—Dactinomycin—kidney cancer	1.82e-05	0.000152	CcSEcCtD
Paclitaxel—Chills—Capecitabine—kidney cancer	1.82e-05	0.000152	CcSEcCtD
Paclitaxel—Arrhythmia—Capecitabine—kidney cancer	1.81e-05	0.000151	CcSEcCtD
Paclitaxel—Gastrointestinal disorder—Gemcitabine—kidney cancer	1.81e-05	0.000151	CcSEcCtD
Paclitaxel—Fatigue—Gemcitabine—kidney cancer	1.8e-05	0.000151	CcSEcCtD
Paclitaxel—Gastrointestinal pain—Vincristine—kidney cancer	1.8e-05	0.000151	CcSEcCtD
Paclitaxel—Cardiac arrest—Doxorubicin—kidney cancer	1.79e-05	0.00015	CcSEcCtD
Paclitaxel—Dizziness—Sorafenib—kidney cancer	1.79e-05	0.00015	CcSEcCtD
Paclitaxel—Pain—Gemcitabine—kidney cancer	1.79e-05	0.00015	CcSEcCtD
Paclitaxel—Constipation—Gemcitabine—kidney cancer	1.79e-05	0.00015	CcSEcCtD
Paclitaxel—Nausea—Erlotinib—kidney cancer	1.79e-05	0.00015	CcSEcCtD
Paclitaxel—Alopecia—Capecitabine—kidney cancer	1.79e-05	0.00015	CcSEcCtD
Paclitaxel—Mood swings—Doxorubicin—kidney cancer	1.79e-05	0.000149	CcSEcCtD
Paclitaxel—Diarrhoea—Sunitinib—kidney cancer	1.78e-05	0.000149	CcSEcCtD
Paclitaxel—Ataxia—Doxorubicin—kidney cancer	1.77e-05	0.000148	CcSEcCtD
Paclitaxel—Mental disorder—Capecitabine—kidney cancer	1.77e-05	0.000148	CcSEcCtD
Paclitaxel—Asthenia—Dactinomycin—kidney cancer	1.77e-05	0.000148	CcSEcCtD
Paclitaxel—Blood creatinine increased—Doxorubicin—kidney cancer	1.77e-05	0.000148	CcSEcCtD
Paclitaxel—Malnutrition—Capecitabine—kidney cancer	1.76e-05	0.000147	CcSEcCtD
Paclitaxel—Erythema—Capecitabine—kidney cancer	1.76e-05	0.000147	CcSEcCtD
Paclitaxel—Dehydration—Doxorubicin—kidney cancer	1.75e-05	0.000147	CcSEcCtD
Paclitaxel—Abdominal pain—Vincristine—kidney cancer	1.74e-05	0.000146	CcSEcCtD
Paclitaxel—Body temperature increased—Vincristine—kidney cancer	1.74e-05	0.000146	CcSEcCtD
Paclitaxel—Liver function test abnormal—Doxorubicin—kidney cancer	1.74e-05	0.000146	CcSEcCtD
Paclitaxel—Flatulence—Capecitabine—kidney cancer	1.74e-05	0.000145	CcSEcCtD
Paclitaxel—Dry skin—Doxorubicin—kidney cancer	1.73e-05	0.000145	CcSEcCtD
Paclitaxel—Dysgeusia—Capecitabine—kidney cancer	1.72e-05	0.000144	CcSEcCtD
Paclitaxel—Dizziness—Sunitinib—kidney cancer	1.72e-05	0.000144	CcSEcCtD
Paclitaxel—Feeling abnormal—Gemcitabine—kidney cancer	1.72e-05	0.000144	CcSEcCtD
Paclitaxel—Vomiting—Sorafenib—kidney cancer	1.72e-05	0.000144	CcSEcCtD
Paclitaxel—Orthostatic hypotension—Doxorubicin—kidney cancer	1.72e-05	0.000144	CcSEcCtD
Paclitaxel—Abdominal pain upper—Doxorubicin—kidney cancer	1.72e-05	0.000144	CcSEcCtD
Paclitaxel—Hypokalaemia—Doxorubicin—kidney cancer	1.72e-05	0.000144	CcSEcCtD
Paclitaxel—Rash—Sorafenib—kidney cancer	1.71e-05	0.000143	CcSEcCtD
Paclitaxel—Dermatitis—Sorafenib—kidney cancer	1.71e-05	0.000143	CcSEcCtD
Paclitaxel—Back pain—Capecitabine—kidney cancer	1.7e-05	0.000143	CcSEcCtD
Paclitaxel—Breast disorder—Doxorubicin—kidney cancer	1.7e-05	0.000143	CcSEcCtD
Paclitaxel—Toxic epidermal necrolysis—Doxorubicin—kidney cancer	1.7e-05	0.000142	CcSEcCtD
Paclitaxel—Aspartate aminotransferase increased—Doxorubicin—kidney cancer	1.7e-05	0.000142	CcSEcCtD
Paclitaxel—Headache—Sorafenib—kidney cancer	1.7e-05	0.000142	CcSEcCtD
Paclitaxel—Muscle spasms—Capecitabine—kidney cancer	1.69e-05	0.000142	CcSEcCtD
Paclitaxel—Diarrhoea—Dactinomycin—kidney cancer	1.69e-05	0.000141	CcSEcCtD
Paclitaxel—Nasopharyngitis—Doxorubicin—kidney cancer	1.69e-05	0.000141	CcSEcCtD
Paclitaxel—Alanine aminotransferase increased—Doxorubicin—kidney cancer	1.66e-05	0.000139	CcSEcCtD
Paclitaxel—Muscular weakness—Doxorubicin—kidney cancer	1.66e-05	0.000139	CcSEcCtD
Paclitaxel—Vision blurred—Capecitabine—kidney cancer	1.66e-05	0.000139	CcSEcCtD
Paclitaxel—Vomiting—Sunitinib—kidney cancer	1.66e-05	0.000139	CcSEcCtD
Paclitaxel—Body temperature increased—Gemcitabine—kidney cancer	1.65e-05	0.000138	CcSEcCtD
Paclitaxel—Tremor—Capecitabine—kidney cancer	1.65e-05	0.000138	CcSEcCtD
Paclitaxel—Rash—Sunitinib—kidney cancer	1.64e-05	0.000138	CcSEcCtD
Paclitaxel—Dermatitis—Sunitinib—kidney cancer	1.64e-05	0.000137	CcSEcCtD
Paclitaxel—Abdominal distension—Doxorubicin—kidney cancer	1.64e-05	0.000137	CcSEcCtD
Paclitaxel—Ill-defined disorder—Capecitabine—kidney cancer	1.63e-05	0.000137	CcSEcCtD
Paclitaxel—Headache—Sunitinib—kidney cancer	1.63e-05	0.000137	CcSEcCtD
Paclitaxel—Dysphagia—Doxorubicin—kidney cancer	1.63e-05	0.000136	CcSEcCtD
Paclitaxel—Influenza—Doxorubicin—kidney cancer	1.63e-05	0.000136	CcSEcCtD
Paclitaxel—Anaemia—Capecitabine—kidney cancer	1.63e-05	0.000136	CcSEcCtD
Paclitaxel—Hypersensitivity—Vincristine—kidney cancer	1.62e-05	0.000136	CcSEcCtD
Paclitaxel—Nausea—Sorafenib—kidney cancer	1.61e-05	0.000135	CcSEcCtD
Paclitaxel—Pancreatitis—Doxorubicin—kidney cancer	1.6e-05	0.000134	CcSEcCtD
Paclitaxel—Malaise—Capecitabine—kidney cancer	1.59e-05	0.000133	CcSEcCtD
Paclitaxel—Vertigo—Capecitabine—kidney cancer	1.58e-05	0.000132	CcSEcCtD
Paclitaxel—Asthenia—Vincristine—kidney cancer	1.58e-05	0.000132	CcSEcCtD
Paclitaxel—Syncope—Capecitabine—kidney cancer	1.58e-05	0.000132	CcSEcCtD
Paclitaxel—Leukopenia—Capecitabine—kidney cancer	1.58e-05	0.000132	CcSEcCtD
Paclitaxel—Vomiting—Dactinomycin—kidney cancer	1.57e-05	0.000131	CcSEcCtD
Paclitaxel—Bronchitis—Doxorubicin—kidney cancer	1.57e-05	0.000131	CcSEcCtD
Paclitaxel—Palpitations—Capecitabine—kidney cancer	1.56e-05	0.00013	CcSEcCtD
Paclitaxel—Rash—Dactinomycin—kidney cancer	1.56e-05	0.00013	CcSEcCtD
Paclitaxel—Nausea—Sunitinib—kidney cancer	1.55e-05	0.00013	CcSEcCtD
Paclitaxel—Loss of consciousness—Capecitabine—kidney cancer	1.55e-05	0.00013	CcSEcCtD
Paclitaxel—Pancytopenia—Doxorubicin—kidney cancer	1.55e-05	0.000129	CcSEcCtD
Paclitaxel—Cough—Capecitabine—kidney cancer	1.54e-05	0.000129	CcSEcCtD
Paclitaxel—Neutropenia—Doxorubicin—kidney cancer	1.52e-05	0.000127	CcSEcCtD
Paclitaxel—Dysuria—Doxorubicin—kidney cancer	1.52e-05	0.000127	CcSEcCtD
Paclitaxel—Hypertension—Capecitabine—kidney cancer	1.52e-05	0.000127	CcSEcCtD
Paclitaxel—Upper respiratory tract infection—Doxorubicin—kidney cancer	1.51e-05	0.000127	CcSEcCtD
Paclitaxel—Diarrhoea—Vincristine—kidney cancer	1.51e-05	0.000126	CcSEcCtD
Paclitaxel—Pollakiuria—Doxorubicin—kidney cancer	1.5e-05	0.000126	CcSEcCtD
Paclitaxel—Asthenia—Gemcitabine—kidney cancer	1.5e-05	0.000126	CcSEcCtD
Paclitaxel—Chest pain—Capecitabine—kidney cancer	1.5e-05	0.000125	CcSEcCtD
Paclitaxel—Arthralgia—Capecitabine—kidney cancer	1.5e-05	0.000125	CcSEcCtD
Paclitaxel—Myalgia—Capecitabine—kidney cancer	1.5e-05	0.000125	CcSEcCtD
Paclitaxel—Anxiety—Capecitabine—kidney cancer	1.49e-05	0.000125	CcSEcCtD
Paclitaxel—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—kidney cancer	1.49e-05	0.000125	CcSEcCtD
Paclitaxel—Photosensitivity reaction—Doxorubicin—kidney cancer	1.49e-05	0.000124	CcSEcCtD
Paclitaxel—Weight increased—Doxorubicin—kidney cancer	1.48e-05	0.000124	CcSEcCtD
Paclitaxel—Discomfort—Capecitabine—kidney cancer	1.48e-05	0.000124	CcSEcCtD
Paclitaxel—Pruritus—Gemcitabine—kidney cancer	1.48e-05	0.000124	CcSEcCtD
Paclitaxel—Weight decreased—Doxorubicin—kidney cancer	1.47e-05	0.000123	CcSEcCtD
Paclitaxel—Hyperglycaemia—Doxorubicin—kidney cancer	1.47e-05	0.000123	CcSEcCtD
Paclitaxel—Dry mouth—Capecitabine—kidney cancer	1.47e-05	0.000123	CcSEcCtD
Paclitaxel—Nausea—Dactinomycin—kidney cancer	1.47e-05	0.000123	CcSEcCtD
Paclitaxel—Pneumonia—Doxorubicin—kidney cancer	1.46e-05	0.000122	CcSEcCtD
Paclitaxel—Dizziness—Vincristine—kidney cancer	1.46e-05	0.000122	CcSEcCtD
Paclitaxel—Infestation NOS—Doxorubicin—kidney cancer	1.45e-05	0.000122	CcSEcCtD
Paclitaxel—Infestation—Doxorubicin—kidney cancer	1.45e-05	0.000122	CcSEcCtD
Paclitaxel—Confusional state—Capecitabine—kidney cancer	1.45e-05	0.000121	CcSEcCtD
Paclitaxel—Stevens-Johnson syndrome—Doxorubicin—kidney cancer	1.44e-05	0.000121	CcSEcCtD
Paclitaxel—Oedema—Capecitabine—kidney cancer	1.44e-05	0.00012	CcSEcCtD
Paclitaxel—Diarrhoea—Gemcitabine—kidney cancer	1.43e-05	0.00012	CcSEcCtD
Paclitaxel—Renal failure—Doxorubicin—kidney cancer	1.43e-05	0.00012	CcSEcCtD
Paclitaxel—Infection—Capecitabine—kidney cancer	1.43e-05	0.000119	CcSEcCtD
Paclitaxel—Neuropathy peripheral—Doxorubicin—kidney cancer	1.42e-05	0.000119	CcSEcCtD
Paclitaxel—Stomatitis—Doxorubicin—kidney cancer	1.42e-05	0.000118	CcSEcCtD
Paclitaxel—Shock—Capecitabine—kidney cancer	1.41e-05	0.000118	CcSEcCtD
Paclitaxel—Urinary tract infection—Doxorubicin—kidney cancer	1.41e-05	0.000118	CcSEcCtD
Paclitaxel—Conjunctivitis—Doxorubicin—kidney cancer	1.41e-05	0.000118	CcSEcCtD
Paclitaxel—Nervous system disorder—Capecitabine—kidney cancer	1.41e-05	0.000118	CcSEcCtD
Paclitaxel—Thrombocytopenia—Capecitabine—kidney cancer	1.41e-05	0.000118	CcSEcCtD
Paclitaxel—Tachycardia—Capecitabine—kidney cancer	1.4e-05	0.000117	CcSEcCtD
Paclitaxel—Vomiting—Vincristine—kidney cancer	1.4e-05	0.000117	CcSEcCtD
Paclitaxel—Skin disorder—Capecitabine—kidney cancer	1.4e-05	0.000117	CcSEcCtD
Paclitaxel—Rash—Vincristine—kidney cancer	1.39e-05	0.000116	CcSEcCtD
Paclitaxel—Hyperhidrosis—Capecitabine—kidney cancer	1.39e-05	0.000116	CcSEcCtD
Paclitaxel—Dermatitis—Vincristine—kidney cancer	1.39e-05	0.000116	CcSEcCtD
Paclitaxel—Haematuria—Doxorubicin—kidney cancer	1.38e-05	0.000116	CcSEcCtD
Paclitaxel—Headache—Vincristine—kidney cancer	1.38e-05	0.000116	CcSEcCtD
Paclitaxel—Hepatobiliary disease—Doxorubicin—kidney cancer	1.37e-05	0.000115	CcSEcCtD
Paclitaxel—Epistaxis—Doxorubicin—kidney cancer	1.37e-05	0.000115	CcSEcCtD
Paclitaxel—Anorexia—Capecitabine—kidney cancer	1.37e-05	0.000115	CcSEcCtD
Paclitaxel—Sinusitis—Doxorubicin—kidney cancer	1.36e-05	0.000114	CcSEcCtD
Paclitaxel—Hypotension—Capecitabine—kidney cancer	1.34e-05	0.000112	CcSEcCtD
Paclitaxel—Vomiting—Gemcitabine—kidney cancer	1.33e-05	0.000111	CcSEcCtD
Paclitaxel—Bradycardia—Doxorubicin—kidney cancer	1.33e-05	0.000111	CcSEcCtD
Paclitaxel—Rash—Gemcitabine—kidney cancer	1.32e-05	0.00011	CcSEcCtD
Paclitaxel—Dermatitis—Gemcitabine—kidney cancer	1.32e-05	0.00011	CcSEcCtD
Paclitaxel—Haemoglobin—Doxorubicin—kidney cancer	1.31e-05	0.00011	CcSEcCtD
Paclitaxel—Headache—Gemcitabine—kidney cancer	1.31e-05	0.00011	CcSEcCtD
Paclitaxel—Nausea—Vincristine—kidney cancer	1.31e-05	0.00011	CcSEcCtD
Paclitaxel—Musculoskeletal discomfort—Capecitabine—kidney cancer	1.31e-05	0.00011	CcSEcCtD
Paclitaxel—Rhinitis—Doxorubicin—kidney cancer	1.31e-05	0.000109	CcSEcCtD
Paclitaxel—Haemorrhage—Doxorubicin—kidney cancer	1.3e-05	0.000109	CcSEcCtD
Paclitaxel—Insomnia—Capecitabine—kidney cancer	1.3e-05	0.000109	CcSEcCtD
Paclitaxel—Hypoaesthesia—Doxorubicin—kidney cancer	1.3e-05	0.000109	CcSEcCtD
Paclitaxel—Pharyngitis—Doxorubicin—kidney cancer	1.29e-05	0.000108	CcSEcCtD
Paclitaxel—Paraesthesia—Capecitabine—kidney cancer	1.29e-05	0.000108	CcSEcCtD
Paclitaxel—Urinary tract disorder—Doxorubicin—kidney cancer	1.29e-05	0.000108	CcSEcCtD
Paclitaxel—Oedema peripheral—Doxorubicin—kidney cancer	1.28e-05	0.000108	CcSEcCtD
Paclitaxel—Connective tissue disorder—Doxorubicin—kidney cancer	1.28e-05	0.000107	CcSEcCtD
Paclitaxel—Dyspnoea—Capecitabine—kidney cancer	1.28e-05	0.000107	CcSEcCtD
Paclitaxel—Urethral disorder—Doxorubicin—kidney cancer	1.28e-05	0.000107	CcSEcCtD
Paclitaxel—Dyspepsia—Capecitabine—kidney cancer	1.27e-05	0.000106	CcSEcCtD
Paclitaxel—Visual impairment—Doxorubicin—kidney cancer	1.26e-05	0.000105	CcSEcCtD
Paclitaxel—Decreased appetite—Capecitabine—kidney cancer	1.25e-05	0.000105	CcSEcCtD
Paclitaxel—Nausea—Gemcitabine—kidney cancer	1.24e-05	0.000104	CcSEcCtD
Paclitaxel—Gastrointestinal disorder—Capecitabine—kidney cancer	1.24e-05	0.000104	CcSEcCtD
Paclitaxel—Fatigue—Capecitabine—kidney cancer	1.24e-05	0.000104	CcSEcCtD
Paclitaxel—Erythema multiforme—Doxorubicin—kidney cancer	1.23e-05	0.000103	CcSEcCtD
Paclitaxel—Pain—Capecitabine—kidney cancer	1.23e-05	0.000103	CcSEcCtD
Paclitaxel—Constipation—Capecitabine—kidney cancer	1.23e-05	0.000103	CcSEcCtD
Paclitaxel—Eye disorder—Doxorubicin—kidney cancer	1.22e-05	0.000102	CcSEcCtD
Paclitaxel—Tinnitus—Doxorubicin—kidney cancer	1.22e-05	0.000102	CcSEcCtD
Paclitaxel—Flushing—Doxorubicin—kidney cancer	1.21e-05	0.000101	CcSEcCtD
Paclitaxel—Cardiac disorder—Doxorubicin—kidney cancer	1.21e-05	0.000101	CcSEcCtD
Paclitaxel—Feeling abnormal—Capecitabine—kidney cancer	1.18e-05	9.91e-05	CcSEcCtD
Paclitaxel—Angiopathy—Doxorubicin—kidney cancer	1.18e-05	9.9e-05	CcSEcCtD
Paclitaxel—Immune system disorder—Doxorubicin—kidney cancer	1.18e-05	9.86e-05	CcSEcCtD
Paclitaxel—Gastrointestinal pain—Capecitabine—kidney cancer	1.18e-05	9.84e-05	CcSEcCtD
Paclitaxel—Mediastinal disorder—Doxorubicin—kidney cancer	1.18e-05	9.84e-05	CcSEcCtD
Paclitaxel—Chills—Doxorubicin—kidney cancer	1.17e-05	9.79e-05	CcSEcCtD
Paclitaxel—Arrhythmia—Doxorubicin—kidney cancer	1.16e-05	9.75e-05	CcSEcCtD
Paclitaxel—Alopecia—Doxorubicin—kidney cancer	1.15e-05	9.64e-05	CcSEcCtD
Paclitaxel—Mental disorder—Doxorubicin—kidney cancer	1.14e-05	9.56e-05	CcSEcCtD
Paclitaxel—Urticaria—Capecitabine—kidney cancer	1.14e-05	9.56e-05	CcSEcCtD
Paclitaxel—Body temperature increased—Capecitabine—kidney cancer	1.14e-05	9.51e-05	CcSEcCtD
Paclitaxel—Abdominal pain—Capecitabine—kidney cancer	1.14e-05	9.51e-05	CcSEcCtD
Paclitaxel—Erythema—Doxorubicin—kidney cancer	1.14e-05	9.5e-05	CcSEcCtD
Paclitaxel—Malnutrition—Doxorubicin—kidney cancer	1.14e-05	9.5e-05	CcSEcCtD
Paclitaxel—Flatulence—Doxorubicin—kidney cancer	1.12e-05	9.36e-05	CcSEcCtD
Paclitaxel—Tension—Doxorubicin—kidney cancer	1.11e-05	9.32e-05	CcSEcCtD
Paclitaxel—Dysgeusia—Doxorubicin—kidney cancer	1.11e-05	9.3e-05	CcSEcCtD
Paclitaxel—Nervousness—Doxorubicin—kidney cancer	1.1e-05	9.23e-05	CcSEcCtD
Paclitaxel—Back pain—Doxorubicin—kidney cancer	1.1e-05	9.19e-05	CcSEcCtD
Paclitaxel—Muscle spasms—Doxorubicin—kidney cancer	1.09e-05	9.13e-05	CcSEcCtD
Paclitaxel—Vision blurred—Doxorubicin—kidney cancer	1.07e-05	8.95e-05	CcSEcCtD
Paclitaxel—Hypersensitivity—Capecitabine—kidney cancer	1.06e-05	8.86e-05	CcSEcCtD
Paclitaxel—Ill-defined disorder—Doxorubicin—kidney cancer	1.05e-05	8.81e-05	CcSEcCtD
Paclitaxel—Anaemia—Doxorubicin—kidney cancer	1.05e-05	8.78e-05	CcSEcCtD
Paclitaxel—Agitation—Doxorubicin—kidney cancer	1.04e-05	8.73e-05	CcSEcCtD
Paclitaxel—Asthenia—Capecitabine—kidney cancer	1.03e-05	8.63e-05	CcSEcCtD
Paclitaxel—Malaise—Doxorubicin—kidney cancer	1.02e-05	8.57e-05	CcSEcCtD
Paclitaxel—Vertigo—Doxorubicin—kidney cancer	1.02e-05	8.54e-05	CcSEcCtD
Paclitaxel—Syncope—Doxorubicin—kidney cancer	1.02e-05	8.52e-05	CcSEcCtD
Paclitaxel—Pruritus—Capecitabine—kidney cancer	1.02e-05	8.51e-05	CcSEcCtD
Paclitaxel—Leukopenia—Doxorubicin—kidney cancer	1.02e-05	8.5e-05	CcSEcCtD
Paclitaxel—Palpitations—Doxorubicin—kidney cancer	1e-05	8.4e-05	CcSEcCtD
Paclitaxel—Loss of consciousness—Doxorubicin—kidney cancer	9.98e-06	8.35e-05	CcSEcCtD
Paclitaxel—Cough—Doxorubicin—kidney cancer	9.91e-06	8.29e-05	CcSEcCtD
Paclitaxel—Convulsion—Doxorubicin—kidney cancer	9.84e-06	8.23e-05	CcSEcCtD
Paclitaxel—Diarrhoea—Capecitabine—kidney cancer	9.83e-06	8.23e-05	CcSEcCtD
Paclitaxel—Hypertension—Doxorubicin—kidney cancer	9.8e-06	8.2e-05	CcSEcCtD
Paclitaxel—Myalgia—Doxorubicin—kidney cancer	9.66e-06	8.09e-05	CcSEcCtD
Paclitaxel—Chest pain—Doxorubicin—kidney cancer	9.66e-06	8.09e-05	CcSEcCtD
Paclitaxel—Arthralgia—Doxorubicin—kidney cancer	9.66e-06	8.09e-05	CcSEcCtD
Paclitaxel—Anxiety—Doxorubicin—kidney cancer	9.63e-06	8.06e-05	CcSEcCtD
Paclitaxel—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—kidney cancer	9.6e-06	8.03e-05	CcSEcCtD
Paclitaxel—Discomfort—Doxorubicin—kidney cancer	9.55e-06	7.99e-05	CcSEcCtD
Paclitaxel—Dizziness—Capecitabine—kidney cancer	9.5e-06	7.95e-05	CcSEcCtD
Paclitaxel—Dry mouth—Doxorubicin—kidney cancer	9.45e-06	7.91e-05	CcSEcCtD
Paclitaxel—Confusional state—Doxorubicin—kidney cancer	9.34e-06	7.82e-05	CcSEcCtD
Paclitaxel—Oedema—Doxorubicin—kidney cancer	9.26e-06	7.75e-05	CcSEcCtD
Paclitaxel—Anaphylactic shock—Doxorubicin—kidney cancer	9.26e-06	7.75e-05	CcSEcCtD
Paclitaxel—Infection—Doxorubicin—kidney cancer	9.2e-06	7.7e-05	CcSEcCtD
Paclitaxel—Vomiting—Capecitabine—kidney cancer	9.14e-06	7.65e-05	CcSEcCtD
Paclitaxel—Shock—Doxorubicin—kidney cancer	9.11e-06	7.63e-05	CcSEcCtD
Paclitaxel—Nervous system disorder—Doxorubicin—kidney cancer	9.09e-06	7.6e-05	CcSEcCtD
Paclitaxel—Thrombocytopenia—Doxorubicin—kidney cancer	9.07e-06	7.59e-05	CcSEcCtD
Paclitaxel—Rash—Capecitabine—kidney cancer	9.06e-06	7.58e-05	CcSEcCtD
Paclitaxel—Dermatitis—Capecitabine—kidney cancer	9.05e-06	7.58e-05	CcSEcCtD
Paclitaxel—Tachycardia—Doxorubicin—kidney cancer	9.04e-06	7.57e-05	CcSEcCtD
Paclitaxel—Headache—Capecitabine—kidney cancer	9e-06	7.54e-05	CcSEcCtD
Paclitaxel—Skin disorder—Doxorubicin—kidney cancer	9e-06	7.53e-05	CcSEcCtD
Paclitaxel—Hyperhidrosis—Doxorubicin—kidney cancer	8.96e-06	7.5e-05	CcSEcCtD
Paclitaxel—Anorexia—Doxorubicin—kidney cancer	8.83e-06	7.39e-05	CcSEcCtD
Paclitaxel—Hypotension—Doxorubicin—kidney cancer	8.66e-06	7.25e-05	CcSEcCtD
Paclitaxel—Nausea—Capecitabine—kidney cancer	8.54e-06	7.14e-05	CcSEcCtD
Paclitaxel—Musculoskeletal discomfort—Doxorubicin—kidney cancer	8.44e-06	7.06e-05	CcSEcCtD
Paclitaxel—Insomnia—Doxorubicin—kidney cancer	8.38e-06	7.01e-05	CcSEcCtD
Paclitaxel—Paraesthesia—Doxorubicin—kidney cancer	8.32e-06	6.96e-05	CcSEcCtD
Paclitaxel—Dyspnoea—Doxorubicin—kidney cancer	8.26e-06	6.91e-05	CcSEcCtD
Paclitaxel—Somnolence—Doxorubicin—kidney cancer	8.24e-06	6.89e-05	CcSEcCtD
Paclitaxel—Dyspepsia—Doxorubicin—kidney cancer	8.15e-06	6.83e-05	CcSEcCtD
Paclitaxel—Decreased appetite—Doxorubicin—kidney cancer	8.05e-06	6.74e-05	CcSEcCtD
Paclitaxel—Gastrointestinal disorder—Doxorubicin—kidney cancer	8e-06	6.69e-05	CcSEcCtD
Paclitaxel—Fatigue—Doxorubicin—kidney cancer	7.99e-06	6.68e-05	CcSEcCtD
Paclitaxel—Constipation—Doxorubicin—kidney cancer	7.92e-06	6.63e-05	CcSEcCtD
Paclitaxel—Pain—Doxorubicin—kidney cancer	7.92e-06	6.63e-05	CcSEcCtD
Paclitaxel—Feeling abnormal—Doxorubicin—kidney cancer	7.63e-06	6.39e-05	CcSEcCtD
Paclitaxel—Gastrointestinal pain—Doxorubicin—kidney cancer	7.58e-06	6.34e-05	CcSEcCtD
Paclitaxel—Urticaria—Doxorubicin—kidney cancer	7.36e-06	6.16e-05	CcSEcCtD
Paclitaxel—Abdominal pain—Doxorubicin—kidney cancer	7.32e-06	6.13e-05	CcSEcCtD
Paclitaxel—Body temperature increased—Doxorubicin—kidney cancer	7.32e-06	6.13e-05	CcSEcCtD
Paclitaxel—Hypersensitivity—Doxorubicin—kidney cancer	6.83e-06	5.71e-05	CcSEcCtD
Paclitaxel—Asthenia—Doxorubicin—kidney cancer	6.65e-06	5.56e-05	CcSEcCtD
Paclitaxel—Pruritus—Doxorubicin—kidney cancer	6.55e-06	5.49e-05	CcSEcCtD
Paclitaxel—Diarrhoea—Doxorubicin—kidney cancer	6.34e-06	5.31e-05	CcSEcCtD
Paclitaxel—Dizziness—Doxorubicin—kidney cancer	6.13e-06	5.13e-05	CcSEcCtD
Paclitaxel—Vomiting—Doxorubicin—kidney cancer	5.89e-06	4.93e-05	CcSEcCtD
Paclitaxel—Rash—Doxorubicin—kidney cancer	5.84e-06	4.89e-05	CcSEcCtD
Paclitaxel—Dermatitis—Doxorubicin—kidney cancer	5.84e-06	4.88e-05	CcSEcCtD
Paclitaxel—Headache—Doxorubicin—kidney cancer	5.8e-06	4.86e-05	CcSEcCtD
Paclitaxel—Nausea—Doxorubicin—kidney cancer	5.5e-06	4.61e-05	CcSEcCtD
Paclitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—kidney cancer	3.69e-06	6.99e-05	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—SCARB1—kidney cancer	3.68e-06	6.97e-05	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—PTGS1—kidney cancer	3.67e-06	6.96e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—kidney cancer	3.66e-06	6.94e-05	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—PTGS1—kidney cancer	3.64e-06	6.9e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—CA2—kidney cancer	3.63e-06	6.87e-05	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	3.61e-06	6.84e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—ALDH1A1—kidney cancer	3.61e-06	6.84e-05	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—PSMD7—kidney cancer	3.6e-06	6.83e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	3.59e-06	6.81e-05	CbGpPWpGaD
Paclitaxel—ABCB11—Metabolism—CYP1A1—kidney cancer	3.58e-06	6.79e-05	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—SLC2A1—kidney cancer	3.58e-06	6.79e-05	CbGpPWpGaD
Paclitaxel—ABCC2—Transmembrane transport of small molecules—RAF1—kidney cancer	3.57e-06	6.77e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—CDKN2B—kidney cancer	3.57e-06	6.77e-05	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—PSMD7—kidney cancer	3.57e-06	6.77e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—kidney cancer	3.57e-06	6.76e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—ALAD—kidney cancer	3.53e-06	6.69e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Transmembrane transport of small molecules—RAF1—kidney cancer	3.53e-06	6.69e-05	CbGpPWpGaD
Paclitaxel—BCL2—Innate Immune System—PIK3CA—kidney cancer	3.48e-06	6.6e-05	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	3.48e-06	6.58e-05	CbGpPWpGaD
Paclitaxel—TUBB4B—Cell Cycle—TP53—kidney cancer	3.47e-06	6.58e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—SLC5A3—kidney cancer	3.46e-06	6.55e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—PGK1—kidney cancer	3.46e-06	6.55e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—PDHB—kidney cancer	3.45e-06	6.54e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—ST3GAL2—kidney cancer	3.45e-06	6.53e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Biological oxidations—POMC—kidney cancer	3.44e-06	6.51e-05	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—BCHE—kidney cancer	3.42e-06	6.47e-05	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—RAF1—kidney cancer	3.41e-06	6.46e-05	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—RELA—kidney cancer	3.4e-06	6.43e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—LDHB—kidney cancer	3.39e-06	6.43e-05	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—BCHE—kidney cancer	3.39e-06	6.42e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—CA9—kidney cancer	3.38e-06	6.4e-05	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—ERBB2—kidney cancer	3.37e-06	6.39e-05	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—SLC5A5—kidney cancer	3.37e-06	6.39e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—ALDH1A1—kidney cancer	3.37e-06	6.39e-05	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—SLC5A5—kidney cancer	3.34e-06	6.34e-05	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—MTOR—kidney cancer	3.33e-06	6.31e-05	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—CD4—kidney cancer	3.32e-06	6.3e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—CRABP1—kidney cancer	3.31e-06	6.28e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	3.3e-06	6.25e-05	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—SLC2A1—kidney cancer	3.26e-06	6.17e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—CCBL1—kidney cancer	3.24e-06	6.14e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—SLC5A3—kidney cancer	3.23e-06	6.12e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—PGK1—kidney cancer	3.23e-06	6.12e-05	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—SLC2A1—kidney cancer	3.23e-06	6.12e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—kidney cancer	3.22e-06	6.11e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—LDHB—kidney cancer	3.17e-06	6e-05	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	3.15e-06	5.96e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	3.13e-06	5.94e-05	CbGpPWpGaD
Paclitaxel—SLCO1B3—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	3.13e-06	5.92e-05	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—CDKN1B—kidney cancer	3.12e-06	5.92e-05	CbGpPWpGaD
Paclitaxel—ABCG2—Transmembrane transport of small molecules—RAF1—kidney cancer	3.11e-06	5.89e-05	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—GSTP1—kidney cancer	3.1e-06	5.88e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—GSTP1—kidney cancer	3.09e-06	5.85e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—ITPR2—kidney cancer	3.08e-06	5.84e-05	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—IL2—kidney cancer	3.06e-06	5.79e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—kidney cancer	3.05e-06	5.78e-05	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	3.03e-06	5.74e-05	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—GSTP1—kidney cancer	2.99e-06	5.66e-05	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—JUN—kidney cancer	2.97e-06	5.64e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—kidney cancer	2.97e-06	5.62e-05	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—CTNNB1—kidney cancer	2.95e-06	5.59e-05	CbGpPWpGaD
Paclitaxel—ABCB11—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	2.94e-06	5.58e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—CA9—kidney cancer	2.94e-06	5.57e-05	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—ABCB1—kidney cancer	2.94e-06	5.56e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—ABCB1—kidney cancer	2.92e-06	5.54e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—kidney cancer	2.9e-06	5.5e-05	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—PTEN—kidney cancer	2.88e-06	5.45e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—CRABP1—kidney cancer	2.87e-06	5.44e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—HIF1A—kidney cancer	2.86e-06	5.41e-05	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—GSTM1—kidney cancer	2.85e-06	5.4e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—TSC2—kidney cancer	2.85e-06	5.4e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—GSTM1—kidney cancer	2.84e-06	5.38e-05	CbGpPWpGaD
Paclitaxel—SLCO1B3—Metabolism—POMC—kidney cancer	2.84e-06	5.38e-05	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—ABCB1—kidney cancer	2.83e-06	5.36e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—PPAT—kidney cancer	2.81e-06	5.33e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—GLIPR1—kidney cancer	2.81e-06	5.33e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—GSTT1—kidney cancer	2.81e-06	5.32e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—ACHE—kidney cancer	2.81e-06	5.32e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—CA9—kidney cancer	2.75e-06	5.21e-05	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—GSTM1—kidney cancer	2.75e-06	5.2e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—kidney cancer	2.74e-06	5.19e-05	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—GSTP1—kidney cancer	2.72e-06	5.15e-05	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—CYP1A1—kidney cancer	2.7e-06	5.12e-05	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—GSTP1—kidney cancer	2.69e-06	5.1e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—CYP1A1—kidney cancer	2.69e-06	5.1e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	2.69e-06	5.09e-05	CbGpPWpGaD
Paclitaxel—ABCB11—Metabolism—POMC—kidney cancer	2.67e-06	5.06e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—ITPR2—kidney cancer	2.67e-06	5.06e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—SCARB1—kidney cancer	2.66e-06	5.04e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—PTGS1—kidney cancer	2.63e-06	4.99e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—FH—kidney cancer	2.61e-06	4.95e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—APRT—kidney cancer	2.61e-06	4.95e-05	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—CYP1A1—kidney cancer	2.6e-06	4.93e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—PSMD7—kidney cancer	2.58e-06	4.89e-05	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—ABCB1—kidney cancer	2.57e-06	4.87e-05	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—ABCB1—kidney cancer	2.55e-06	4.83e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—kidney cancer	2.52e-06	4.77e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—APC—kidney cancer	2.52e-06	4.77e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—KIT—kidney cancer	2.52e-06	4.77e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—CRABP1—kidney cancer	2.5e-06	4.74e-05	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—GSTM1—kidney cancer	2.5e-06	4.73e-05	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—GSTM1—kidney cancer	2.48e-06	4.69e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism of lipids and lipoproteins—POMC—kidney cancer	2.46e-06	4.66e-05	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—MAPK3—kidney cancer	2.46e-06	4.66e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—GPC3—kidney cancer	2.46e-06	4.66e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—BCHE—kidney cancer	2.45e-06	4.64e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—kidney cancer	2.44e-06	4.62e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—GSTT1—kidney cancer	2.43e-06	4.61e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—ACHE—kidney cancer	2.43e-06	4.61e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—SLC5A5—kidney cancer	2.42e-06	4.58e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—CA2—kidney cancer	2.39e-06	4.53e-05	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—CYP1A1—kidney cancer	2.37e-06	4.49e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—BRAF—kidney cancer	2.37e-06	4.48e-05	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—CYP1A1—kidney cancer	2.35e-06	4.45e-05	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—MAPK1—kidney cancer	2.34e-06	4.43e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—CRABP1—kidney cancer	2.34e-06	4.43e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—SLC2A1—kidney cancer	2.33e-06	4.42e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—ALAD—kidney cancer	2.33e-06	4.41e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—ITPR2—kidney cancer	2.32e-06	4.4e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—SCARB1—kidney cancer	2.3e-06	4.36e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—PTGS1—kidney cancer	2.28e-06	4.32e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—ST3GAL2—kidney cancer	2.27e-06	4.31e-05	CbGpPWpGaD
Paclitaxel—SLCO1B3—Metabolism—PTGS2—kidney cancer	2.26e-06	4.29e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—PSMD7—kidney cancer	2.24e-06	4.24e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—ALDH1A1—kidney cancer	2.22e-06	4.21e-05	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	2.22e-06	4.21e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	2.21e-06	4.19e-05	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—KRAS—kidney cancer	2.21e-06	4.19e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—ITPR2—kidney cancer	2.17e-06	4.11e-05	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	2.14e-06	4.05e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—PGK1—kidney cancer	2.13e-06	4.04e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—SLC5A3—kidney cancer	2.13e-06	4.04e-05	CbGpPWpGaD
Paclitaxel—ABCB11—Metabolism—PTGS2—kidney cancer	2.13e-06	4.04e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—ACHE—kidney cancer	2.12e-06	4.02e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—GSTT1—kidney cancer	2.12e-06	4.02e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—BCHE—kidney cancer	2.12e-06	4.02e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—SLC5A5—kidney cancer	2.09e-06	3.97e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—LDHB—kidney cancer	2.09e-06	3.96e-05	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—PIK3CA—kidney cancer	2.03e-06	3.85e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—SLC2A1—kidney cancer	2.02e-06	3.83e-05	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—POMC—kidney cancer	2.01e-06	3.82e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—SCARB1—kidney cancer	2.01e-06	3.8e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—POMC—kidney cancer	2.01e-06	3.8e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism of lipids and lipoproteins—POMC—kidney cancer	2e-06	3.79e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—PTGS1—kidney cancer	1.99e-06	3.76e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—GSTT1—kidney cancer	1.98e-06	3.75e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—ACHE—kidney cancer	1.98e-06	3.75e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—RAF1—kidney cancer	1.98e-06	3.74e-05	CbGpPWpGaD
Paclitaxel—SLCO1B3—Metabolism—PTEN—kidney cancer	1.97e-06	3.74e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	1.96e-06	3.72e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—ERBB2—kidney cancer	1.95e-06	3.7e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—PSMD7—kidney cancer	1.95e-06	3.69e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—GSTP1—kidney cancer	1.95e-06	3.69e-05	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—POMC—kidney cancer	1.94e-06	3.68e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—MTOR—kidney cancer	1.93e-06	3.65e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—CD4—kidney cancer	1.92e-06	3.65e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—PTGS2—kidney cancer	1.91e-06	3.62e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—SCARB1—kidney cancer	1.87e-06	3.55e-05	CbGpPWpGaD
Paclitaxel—ABCB11—Metabolism—PTEN—kidney cancer	1.86e-06	3.52e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—PTGS1—kidney cancer	1.86e-06	3.52e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—BCHE—kidney cancer	1.85e-06	3.5e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—ABCB1—kidney cancer	1.84e-06	3.49e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—SLC5A5—kidney cancer	1.82e-06	3.46e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—PSMD7—kidney cancer	1.82e-06	3.45e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—CA9—kidney cancer	1.81e-06	3.43e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—CDKN1B—kidney cancer	1.81e-06	3.43e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—GSTM1—kidney cancer	1.79e-06	3.39e-05	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—POMC—kidney cancer	1.77e-06	3.34e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—SLC2A1—kidney cancer	1.76e-06	3.34e-05	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—POMC—kidney cancer	1.75e-06	3.32e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—BCHE—kidney cancer	1.73e-06	3.27e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	1.71e-06	3.24e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—CTNNB1—kidney cancer	1.71e-06	3.24e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—SLC5A5—kidney cancer	1.7e-06	3.23e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—CYP1A1—kidney cancer	1.7e-06	3.21e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—GSTP1—kidney cancer	1.69e-06	3.2e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Transmembrane transport of small molecules—RAF1—kidney cancer	1.68e-06	3.18e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—PTEN—kidney cancer	1.67e-06	3.16e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—SLC2A1—kidney cancer	1.65e-06	3.12e-05	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—PTGS2—kidney cancer	1.61e-06	3.05e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—PTGS2—kidney cancer	1.6e-06	3.03e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	1.6e-06	3.03e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—ABCB1—kidney cancer	1.6e-06	3.03e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—GSTM1—kidney cancer	1.55e-06	2.94e-05	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—PTGS2—kidney cancer	1.55e-06	2.93e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—CRABP1—kidney cancer	1.54e-06	2.92e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—GSTP1—kidney cancer	1.47e-06	2.78e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—CYP1A1—kidney cancer	1.47e-06	2.78e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—ITPR2—kidney cancer	1.43e-06	2.71e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—MAPK3—kidney cancer	1.42e-06	2.7e-05	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—PTGS2—kidney cancer	1.41e-06	2.67e-05	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—PTEN—kidney cancer	1.4e-06	2.66e-05	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—PTGS2—kidney cancer	1.4e-06	2.64e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—PTEN—kidney cancer	1.4e-06	2.64e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	1.39e-06	2.64e-05	CbGpPWpGaD
Paclitaxel—SLCO1B3—Metabolism—PIK3CA—kidney cancer	1.39e-06	2.64e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—MYC—kidney cancer	1.38e-06	2.62e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—GSTP1—kidney cancer	1.37e-06	2.6e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—MAPK1—kidney cancer	1.35e-06	2.57e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—GSTM1—kidney cancer	1.35e-06	2.56e-05	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—PTEN—kidney cancer	1.35e-06	2.56e-05	CbGpPWpGaD
Paclitaxel—ABCB11—Metabolism—PIK3CA—kidney cancer	1.31e-06	2.48e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—ACHE—kidney cancer	1.31e-06	2.47e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—GSTT1—kidney cancer	1.31e-06	2.47e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—ABCB1—kidney cancer	1.3e-06	2.46e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—CYP1A1—kidney cancer	1.28e-06	2.43e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—KRAS—kidney cancer	1.28e-06	2.42e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—POMC—kidney cancer	1.26e-06	2.4e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—GSTM1—kidney cancer	1.26e-06	2.39e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—SCARB1—kidney cancer	1.24e-06	2.34e-05	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—PTEN—kidney cancer	1.23e-06	2.33e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—PTGS1—kidney cancer	1.22e-06	2.32e-05	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—PTEN—kidney cancer	1.22e-06	2.31e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	1.21e-06	2.29e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—PSMD7—kidney cancer	1.2e-06	2.27e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—CYP1A1—kidney cancer	1.2e-06	2.27e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—PIK3CA—kidney cancer	1.18e-06	2.23e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—BCHE—kidney cancer	1.14e-06	2.16e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—SLC5A5—kidney cancer	1.12e-06	2.13e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—POMC—kidney cancer	1.1e-06	2.08e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—SLC2A1—kidney cancer	1.09e-06	2.06e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—PTGS2—kidney cancer	1.01e-06	1.91e-05	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—PIK3CA—kidney cancer	9.89e-07	1.87e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—PIK3CA—kidney cancer	9.84e-07	1.87e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	9.82e-07	1.86e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—POMC—kidney cancer	9.54e-07	1.81e-05	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—PIK3CA—kidney cancer	9.52e-07	1.8e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—GSTP1—kidney cancer	9.05e-07	1.72e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—POMC—kidney cancer	8.92e-07	1.69e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—PTEN—kidney cancer	8.8e-07	1.67e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—PTGS2—kidney cancer	8.74e-07	1.66e-05	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—PIK3CA—kidney cancer	8.66e-07	1.64e-05	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—PIK3CA—kidney cancer	8.59e-07	1.63e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—ABCB1—kidney cancer	8.57e-07	1.62e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—GSTM1—kidney cancer	8.32e-07	1.58e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—CYP1A1—kidney cancer	7.89e-07	1.49e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—PTEN—kidney cancer	7.62e-07	1.44e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—PTGS2—kidney cancer	7.61e-07	1.44e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—PTGS2—kidney cancer	7.11e-07	1.35e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—PTEN—kidney cancer	6.64e-07	1.26e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—PIK3CA—kidney cancer	6.21e-07	1.18e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—PTEN—kidney cancer	6.2e-07	1.18e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—POMC—kidney cancer	5.88e-07	1.11e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—PIK3CA—kidney cancer	5.38e-07	1.02e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—PTGS2—kidney cancer	4.69e-07	8.89e-06	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—PIK3CA—kidney cancer	4.68e-07	8.87e-06	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—PIK3CA—kidney cancer	4.38e-07	8.29e-06	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—PTEN—kidney cancer	4.09e-07	7.75e-06	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—PIK3CA—kidney cancer	2.89e-07	5.47e-06	CbGpPWpGaD
